Bright Minds Biosciences Inc(DRUG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DRUG Bright Minds Biosciences Inc

Trading 08-28 12:06:02 EDT

72.90

-1.64

-2.20%

High74.32	Low72.50	Vol27.65K
Open74.32	D1 Closing74.54	Amplitude2.44%
Mkt Cap713.44M	Tradable Cap381.81M	Total Shares9.79M
T/O2.03M	T/O Rate0.53%	Tradable Shares5.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DRUG","market":"US","secType":"STK","nameCN":"Bright Minds Biosciences Inc","latestPrice":72.895,"timestamp":1787933160634,"preClose":74.535,"halted":0,"volume":27646,"delay":0,"changeRate":-0.022003085798618108,"floatShares":5237800,"shares":9787161,"eps":-2.012875,"marketStatus":"Trading","change":-1.64,"latestTime":"08-28 12:06:02 EDT","open":74.32,"high":74.32,"low":72.5,"amount":2028654.7438639998,"amplitude":0.024418,"askPrice":72.79,"askSize":2,"bidPrice":71.77,"bidSize":7,"shortable":3,"etf":0,"ttmEps":-2.012875,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787947200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":74.535,"preHourTrading":{"tag":"盘前","latestPrice":76.35,"preClose":74.535,"latestTime":"09:25 EDT","volume":42,"amount":3156.74982,"timestamp":1787923522376,"change":1.815,"changeRate":0.024351,"amplitude":0.018112},"postHourTrading":{"tag":"盘后","latestPrice":74.535,"preClose":74.535,"latestTime":"19:30 EDT","volume":418,"amount":31157.5,"timestamp":1787873402217,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.607091,"impliedVol":0.5412,"impliedVolPercentile":0.0256},"requestUrl":"/m/hq/s/DRUG/tweets","defaultTab":"tweets","newsList":[{"id":"2659158478","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158478?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ·ADC Ther. Ltd                                   2Q      (.22)   7:30 AM. ·Applied Ind Tech                                 4Q      2.92    6:30 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BZAI","ESEA","ACXP","VIPS","AEBI","CAMP","DDS","BSP","BIRK","AVR","AIRJ","BAK","CAAP","STNE","ABEO","BLTE","AMAT","ALH","BN","ADCT","ARCO","BEAT","CAN","AVAH","CLRB","CRMD","CELC","EVTL","BTBT","DEFT","ETON","AIT","DARE","EU","ASND","DCGO","AIRO","CAPR","FBRX","BRUN","DLO","CLBT","CRDL","AEYE","ARX","BAP","DRUG","ACOG","ELMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658214952","title":"Bright Minds Biosciences Inc. Expected to Post a Loss of C$1.76 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658214952","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658214952?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:46","pubTimestamp":1786398364,"startTime":"0","endTime":"0","summary":"Bright Minds Biosciences Inc. <DRUG.CD> expected to post a loss of C$1.76 a share - Earnings PreviewBright Minds Biosciences Inc.DRUG.CDis expected to  show no change in quarterly revenue when it repo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N447245:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646389896","title":"H.C. Wainwright Keeps Their Buy Rating on Bright Minds Biosciences (DRUG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646389896","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646389896?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:45","pubTimestamp":1782420322,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Bright Minds Biosciences, with a price target of $145....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-bright-minds-biosciences-drug-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-bright-minds-biosciences-drug-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642435742","title":"Bright Minds Biosciences (DRUG) Receives a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2642435742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642435742?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:35","pubTimestamp":1780940122,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Bright Minds Biosciences today and set a price target of $145.00. Trucchio cove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bright-minds-biosciences-drug-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bright-minds-biosciences-drug-receives-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638526176","title":"Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638526176","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638526176?lang=en_us&edition=fundamental","pubTime":"2026-05-27 07:18","pubTimestamp":1779837480,"startTime":"0","endTime":"0","summary":"NEW YORK, May  26, 2026  (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/26/3301576/0/en/Bright-Minds-Biosciences-to-Present-at-Jefferies-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XBI","XLV","BK4137","BK4585","LU0029874061.USD","BK4135","BK4139","DRUG","HCSG","CNS","LU0128526141.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637804619","title":"Bright Minds Biosciences (DRUG) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2637804619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637804619?lang=en_us&edition=fundamental","pubTime":"2026-05-21 13:45","pubTimestamp":1779342324,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Joseph Thome maintained a Buy rating on Bright Minds Biosciences yesterday. The company’s shares closed yesterday at C$111.87. Acc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bright-minds-biosciences-drug-receives-a-buy-from-td-cowen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bright-minds-biosciences-drug-receives-a-buy-from-td-cowen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4566","BK4585","BK4139","TD","BK4127","DRUG","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636509849","title":"Piper Sandler Issues a Buy Rating on Bright Minds Biosciences (DRUG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636509849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636509849?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:55","pubTimestamp":1779274515,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi assigned a Buy rating to Bright Minds Biosciences today and set a price target of $220.00. According to TipRan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-issues-a-buy-rating-on-bright-minds-biosciences-drug-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-issues-a-buy-rating-on-bright-minds-biosciences-drug-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636162018","title":"U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv","url":"https://stock-news.laohu8.com/highlight/detail?id=2636162018","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636162018?lang=en_us&edition=fundamental","pubTime":"2026-05-20 15:07","pubTimestamp":1779260842,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, VertivMay 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CAVA Gro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4N41X0MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC","BMRN","JAZZ","CNC","LMRI","HD","HSY","GGLS","DVN","CRWD","HALO","APA","KEYS","WHD","INSM","CNCG","LRCU","AMZN","CVS","AMZD","HUM","EOG","LRCX","MIRM","DRUG","KLAC","MRVL","META","ELV","IONS","S","INCY","BRO","GOOGL","ALNY","AMZY","EBAY","FANG","CHRW","EXP","MVLL","DKS","CRWL","AMRX","CAVA","AMZU","USAW.SI","MRVU","GGLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634423757","title":"Bright Minds Biosciences Inc  expected to post a loss of C$1.19 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634423757","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634423757?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:13","pubTimestamp":1778530402,"startTime":"0","endTime":"0","summary":"Bright Minds Biosciences Inc  expected to post a loss of C$1.19 a share - Earnings Preview Bright Minds Biosciences Inc DRUG.CD  is expected to  show no change in quarterly revenue when it reports  re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616553265","title":"Bright Minds price target raised to $145 from $115 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616553265?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:39","pubTimestamp":1772631587,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Bright Minds (DRUG) to $145 from $115 and keeps a Buy rating on the shares. The firm says the BRE...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bright-minds-price-target-raised-to-145-from-115-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bright-minds-price-target-raised-to-145-from-115-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRUG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616553758","title":"Bright Minds Biosciences Inc : H.c. Wainwright Raises Target Price to $145 From $115","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616553758?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:34","pubTimestamp":1772631241,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nFWN3ZS21A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DRUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614050718","title":"Bright Minds Biosciences to Present at Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2614050718","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614050718?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:30","pubTimestamp":1772055000,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb.  25, 2026  (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/25/3245072/0/en/Bright-Minds-Biosciences-to-Present-at-Upcoming-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRUG","CNS","BK4139","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612513914","title":"Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG","url":"https://stock-news.laohu8.com/highlight/detail?id=2612513914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612513914?lang=en_us&edition=fundamental","pubTime":"2026-02-17 19:56","pubTimestamp":1771329367,"startTime":"0","endTime":"0","summary":"BTIG analyst Thomas Shrader has maintained their bullish stance on DRUG stock, giving a Buy rating on February 13. Thomas Shrader has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/compelling-phase-2-data-and-prader-willi-upside-support-buy-rating-and-favorable-risk-reward-for-drug-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/compelling-phase-2-data-and-prader-willi-upside-support-buy-rating-and-favorable-risk-reward-for-drug-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRUG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.brightmindsbio.com","stockEarnings":[{"period":"1week","weight":-0.0512},{"period":"1month","weight":0.0358},{"period":"3month","weight":-0.1537},{"period":"6month","weight":-0.1108},{"period":"1year","weight":0.719},{"period":"ytd","weight":-0.0449}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.037856},{"month":2,"riseRate":0.4,"avgChangeRate":-0.066416},{"month":3,"riseRate":0,"avgChangeRate":-0.20093},{"month":4,"riseRate":0.4,"avgChangeRate":-0.018901},{"month":5,"riseRate":0.6,"avgChangeRate":0.054922},{"month":6,"riseRate":0.2,"avgChangeRate":-0.131991},{"month":7,"riseRate":1,"avgChangeRate":0.220984},{"month":8,"riseRate":0.6,"avgChangeRate":0.105789},{"month":9,"riseRate":0.5,"avgChangeRate":0.012143},{"month":10,"riseRate":0.25,"avgChangeRate":9.6378},{"month":11,"riseRate":0.5,"avgChangeRate":0.078078},{"month":12,"riseRate":0.4,"avgChangeRate":-0.11205}],"exchange":"NASDAQ","name":"Bright Minds Biosciences Inc","nameEN":"Bright Minds Biosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bright Minds Biosciences Inc(DRUG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bright Minds Biosciences Inc(DRUG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bright Minds Biosciences Inc,DRUG,Bright Minds Biosciences Inc股票,Bright Minds Biosciences Inc股票老虎,Bright Minds Biosciences Inc股票老虎国际,Bright Minds Biosciences Inc行情,Bright Minds Biosciences Inc股票行情,Bright Minds Biosciences Inc股价,Bright Minds Biosciences Inc股市,Bright Minds Biosciences Inc股票价格,Bright Minds Biosciences Inc股票交易,Bright Minds Biosciences Inc股票购买,Bright Minds Biosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bright Minds Biosciences Inc(DRUG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bright Minds Biosciences Inc(DRUG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction